Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N F Hacker

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
Gynecologic Oncology|August 1, 1982
Management of postexenteration perineal hernias by myocutaneous axial flapsR S Leuchter, L D Lagasse, N F Hacker, et al.
Obstetrics and Gynecology|January 1, 1982
Levator ani transposition for anal incompetence secondary to sphincter damageJ S Berek, L D Lagasse, N F Hacker, et al.
Current Problems in Cancer|March 1, 1988
Uterine corpus and cervical cancerJ S Berek, N F Hacker, K D Hatch, et al.
Cancer|August 5, 2000
Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 casesJ J Low, L C Perrin, A J Crandon, et al.
Obstetrics and Gynecology|July 1, 1983
Microinvasive carcinoma of the vulvaN F Hacker, J S Berek, L D Lagasse, et al.
Gynecologic Oncology|February 1, 1982
Lower urinary tract resection as part of cytoreductive surgery for ovarian cancerJ S Berek, N F Hacker, L D Lagasse, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|May 1, 1982
Positive peritoneal cytology in corpus carcinoma. Report of a fatal outcomeN F Hacker, T W Castaldok, C P Morrow, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 14, 2004
Malignant perivascular epithelioid cell tumor (PEComa) arising in the broad ligamentD Fink, D E Marsden, L Edwards, et al.
Oncogenesis|May 31, 2016
Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancerC E Henry, E Llamosas, A Djordjevic, et al.
The Journal of Obstetrics and Gynaecology Research|March 6, 1999
Interleukin-6 (IL-6) does not change the expression of Bcl-2 protein in the prevention of cisplatin-induced apoptosis in ovarian cancer cell linesS Ishioka, C van Haaften-Day, S Sagae, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Gynecologic Oncology|August 1, 1982
Management of postexenteration perineal hernias by myocutaneous axial flapsR S Leuchter, L D Lagasse, N F Hacker, et al.
Obstetrics and Gynecology|January 1, 1982
Levator ani transposition for anal incompetence secondary to sphincter damageJ S Berek, L D Lagasse, N F Hacker, et al.
Current Problems in Cancer|March 1, 1988
Uterine corpus and cervical cancerJ S Berek, N F Hacker, K D Hatch, et al.
Cancer|August 5, 2000
Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 casesJ J Low, L C Perrin, A J Crandon, et al.
Obstetrics and Gynecology|July 1, 1983
Microinvasive carcinoma of the vulvaN F Hacker, J S Berek, L D Lagasse, et al.
Gynecologic Oncology|February 1, 1982
Lower urinary tract resection as part of cytoreductive surgery for ovarian cancerJ S Berek, N F Hacker, L D Lagasse, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|May 1, 1982
Positive peritoneal cytology in corpus carcinoma. Report of a fatal outcomeN F Hacker, T W Castaldok, C P Morrow, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 14, 2004
Malignant perivascular epithelioid cell tumor (PEComa) arising in the broad ligamentD Fink, D E Marsden, L Edwards, et al.
Oncogenesis|May 31, 2016
Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancerC E Henry, E Llamosas, A Djordjevic, et al.
The Journal of Obstetrics and Gynaecology Research|March 6, 1999
Interleukin-6 (IL-6) does not change the expression of Bcl-2 protein in the prevention of cisplatin-induced apoptosis in ovarian cancer cell linesS Ishioka, C van Haaften-Day, S Sagae, et al.
Pageof 13